Clinical Trial Update: Anidulafungin In Treatment Of Candidemia In Asian Subjects [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating anidulafungin for treating candidemia in Asian subjects has completed and posted results. The study assessed efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidemia | Phase 3 | Status: COMPLETED | Results posted: 2010-02-17